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The tubulin molecule consists of an a- and a B-subunit, each of which exists in several isotypic forms. It has been previous- 
ly shown that one of the isotypes of neuroblastoma fi-tubulin is phosphorylated at a serine residue in vivo [(1985) J. 
Cell Biol. 100, 7647741. Here we identify the phosphorylated isotype as jI, (type III). Moreover, the large size of the 
phosphorylated tryptic peptide and sequence comparisons of vertebrate /I-tubulins suggest hat one of the two serines 
in positions 444 and 446 is the phosphorylated residue. Our results raise the possibility that &tubulin differs functionally 
from the other &tubulin isotypes. 
/I-Tubulin; Tubulin isotype; Tubulin phosphorylation; Neuroblastoma tubulin 
1. INTRODUCTION 
Microtubules are cylindrical organelles involved 
in a variety of cellular processes, such as mitosis, 
transport and ciliary and flagellar motility [ 11. The 
precise mechanisms by which microtubule 
assembly is regulated in vivo are unknown. One 
possible mechanism is phosphorylation, a 
widespread regulator of enzyme function. 
Cytoskeletal proteins, including the microtubule- 
associated proteins (MAPS) are known to be highly 
phosphorylated in vivo, but little is known about 
the phosphorylation of tubulin, the building block 
subunit of microtubules [2-41. The tubulin 
molecule (100 kDa) is a heterodimer of two 
50 kDa subunits, designated a and fl [5]. 
Phosphorylation of &tubulin in vivo was first 
noted by Eipper [6] using rat brain slices incubated 
in organ culture in the presence of [32P]or- 
thophosphate. Eipper [7] observed that the 
phosphorylation was in the C-terminal tryptic pep- 
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tide. Later, Gard and Kirschner [8] observed that 
an isotype of @-tubulin in neuroblastoma cells was 
phosphorylated in vivo when the cells were induced 
to differentiate in the presence of [32P]or- 
thophosphate. The sequences of the various 
isotypes of ,@tubulin are now known and it ap- 
pears likely that there may be functionally signifi- 
cant differences between them [9-121. Gard and 
Kirschner [8] did not, however, determine which of 
the isotypes of ,&tubulin is phosphorylated, nor in 
which part of the protein it is phosphorylated. 
More recently, Serrano et al. [13] repeated the ex- 
periments of Gard and Kirschner [S] and located 
the radioactive serine in the C-terminal tryptic pep- 
tide; by hydrolyzing that peptide with CNBr and 
analyzing the resulting fragments, they tentatively 
identified the radioactive serine as that in position 
423 [13]. Serrano et al. [13], however, also in- 
dicated that if the phosphorylated isotype was the 
neuronal specific fl-tubulin isotype (type III) then 
the labeled residue could be much closer to the C- 
terminus [ 131. This tubulin isotype has unique 
serines near the C-terminus [9] and using their ap- 
proach they would not have been able to rule out 
the possibility of these residues being 
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phosphorylated if indeed type III tubulin is the 
phosphorylated isotype. 
We took advantage of the fact that the type III 
isotype, which we previously designated ,&, has a 
markedly lower electrophoretic mobility after car- 
boxymethylation than any of the other vertebrate 
fl-isotypes [ 14- 171; we incubated neuroblastoma 
cells in vivo with [32P]orthophosphate and found 
that the ,&-isotype of tubulin is the one that 
becomes phosphorylated. Moreover, the site of 
phosphorylation is probably one of the two serines 
near the C-terminus of ,&. Since the C-terminal 
region of B-tubulin is known to be the site where 
the MAPS bind and since ,& lacks the MAP- 
binding site [ 181, our results raise the possibility 
that tubulin isotypes in the brain may have their 
assembly regulated in different fashions. 
2. MATERIALS AND METHODS 
GTP and Na iodoacetate were from Serva (Heidelberg, 
FRG). Affinity purified trypsin was the kind gift of Dr K.D. 
Jany [19]. Sephadex G-50 and Sephadex G-10 were from Phar- 
macia (Uppsala, Sweden). [32P]Orthophosphate (5 mCi/ml) 
was from Amersham (Buchler, Braunschweig, FRG). Dulbec- 
co’s minimal essential medium was from Biochrom (Berlin). 
Nitrocellulose sheets were from Schleicher and Schuell (Dassel, 
FRG) and X-omat AR X-ray film was from Eastman Kodak 
(Rochester, NY). 
Twice-cycled pig brain microtubule protein (CzS) was the 
kind gift of Dr Karl Doenges and Joachim Buchholz. It was 
prepared at a protein concentration f 20 mg/ml in 0.1 M 
Pipes, pH 6.9, 1 mM MgClr, 0.1 mM EDTA, 1 mM EGTA and 
stored at - 80°C. After being thawed, the CzS was made 1 mM 
in GTP and incubated at 37°C to allow microtubules to 
polymerize. The microtubules were centrifuged at 20000 x g (in 
a 50 Ti rotor) for 80 min at 30°C. The resulting pellets, each 
one containing 12 mg of protein, were stored at -72°C until 
use. During an experiment where neuroblastoma tubulin was to 
be used, a pig brain microtubule pellet was resuspended in 
0.7 ml of a buffer (PB) consisting of 0.1 M Mes, pH 6.55, 
0.5 mM MgClr, 2 mM ethyleneglycol-bis-(&aminoethyl ether), 
N,N ‘-tetraacetic acid, 0.1 mM EDTA, 1 mM ATP, 1 mM j3- 
mercaptoethanol, 1mM GTP, 10 mM NaF, 10 fig/ml pepstatin 
A, 10 pg/ml o-phenanthroline, 10 pg/ml leupeptin, 10 pg/ml 
aprotinin, 1 mM phenylmethylsulfonyl fluoride and 1 mM 
benzamidine-HCl. The suspension was then incubated at 0°C 
for 30-60 min and was then centrifuged at 160000 x g for 
5 min at 4°C in a Beckman airfuge. The resulting supernatant, 
designated CsS, was then mixed with the neuroblastoma protein 
as described below. 
Neuroblastoma 2A cells (CCL 131) obtained from the 
American Type Culture Collection were maintained in DMEM 
with 10% fetal calf serum. For some experiments, the cells were 
transferred into five 75 ml flasks and were allowed to grow for 
three days in the presence of DMEM and 2% dimethylsulfox- 
ide, but no fetal calf serum. They were then placed in DMEM, 
lacking both dimethylsulfoxide and fetal calf serum. After 4 
days, the cells were placed in medium identical to the previous 
one, but lacking phosphate. For other experiments, the cells 
were grown for 9 days in DMEM containing 0.2% fetal calf 
serum and 2% dimethylsulfoxide and then transferred into 
medium lacking fetal calf serum and dimethylsulfoxide for 7 
days prior to transfer to phosphate-free medium. Both pro- 
tocols led to considerable neurite outgrowth, similar to that 
seen by Gard and Kirschner [S] (fig.1). 1 mC [32P]or- 
thophosphate was then added to each bottle. After 20 h of in- 
cubation, the cells were harvested and processed according to 
Gard and Kirschner [8]. The neuroblastoma cell extract (about 
0.2 ml) was passed by centrifugation through two 2 ml columns 
of Sephadex G-10 and was then mixed with 0.3 ml of pig brain 
microtubule protein (CsS, 9 mg/ml). The mixture was then in- 
cubated at 37°C for 30 min and then layered on top of PB con- 
taining 50% sucrose in an airfuge tube and centrifuged at 
160000 x g for 20 min at 25°C. The pellets were then reduced 
and carboxymethylated [20] and subjected to electrophoresis on 
5.5% polyacrylamide gels containing 1% Na dodecyl sulfate 
1211. For preparative gel electrophoresis, the sample was made 
5% in trichloroacetic acid at 0°C and then centrifuged to 
remove any residual free [32P]orthophosphate. The pellet was 
resuspended in 5% trichloroacetic acid and centrifuged again 
and then resuspended in the Laemmli gel sample buffer and 
subjected to electrophoresis on a 5.5% polyacrylamide slab. 
The a, /?I, and & bands were visualized in 4 M Na acetate, ex- 
tracted from the gel, dialyzed extensively against water and 
lyophilized [22]. 
The br-tubulin was mixed with previously purified &tubulin 
(0.4 mg/ml) in 0.05 M NH4HCOs. To this was added 20 pg of 
trypsin and the digestion carried out for 7 h at 37°C. The digest 
was then lyophilized and dissolved in 200 /rl of 8 M urea, 0.1 M 
N&HCOs and applied to a column of Sephadex G-50. The 
fractions were pooled as shown in fig.3 and the individual pools 
were subjected to chromatography on a column of Sephadex 
G-10 equilibrated in 0.1 M NH.+HCOx to remove the urea. 
Samples from this column were lyophilized. 
Protein concentrations were determined by the method of 
Lowry et al. [23] as modified by Schacterle and Pollack [24], us- 
ing bovine serum albumin as a standard. 
Gels were dried on a slab gel dryer. Peptides were dissolved 
in water and spotted on nitrocellulose. 
3. RESULTS AND DISCUSSION 
Neuroblastoma cells that were induced to dif- 
ferentiate developed an extensive network of 
neurites (fig.1). The cells were incubated with 
[32P]orthophosphate and a cell extract was 
prepared as described above. Microtubule protein 
from pig brain that had been mixed and co- 
polymerized with 32P-labeled neuroblastoma cell 
extract was reduced and carboxymethylated and 
subjected to electrophoresis on polyacrylamide 
gels. Autoradiography of the gels (fig.2) revealed 
the presence of radioactivity that co-migrated with 
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Fig.1. Micrograph of neuroblastoma cells. The figure shows 
two phase-contrast micrographs of neuroblastoma cells in a 
non-differentiated state (A) and in a differentiated state after 
being incubated in the absence of fetal calf serum (B). (x 700). 
the &-band. There was also radioactivity at other 
positions on the gel, but very little label co- 
migrated with either the LY- or the PI-bands. The 
positions of the non-tubulin labeled bands roughly 
matched those seen by Gard and Kirschner [S]. 
Another portion of the radioactive material was 
subjected to electrophoresis and the &band was 
visualized using 4 M Na acetate and sliced from 
the gel. The protein was extracted from the gel slice 
and digested with trypsin. The tryptic digest was 
chromatographed on a column of Sephadex G-50 
and the elution profile is shown in fig.3. The frac- 
tions were pooled in four groups as shown on the 
figure. Each pool was then run on a column of 
Sephadex G-10 to remove the urea. Portions of 
each pool were spotted on nitrocellulose and sub- 
jected to autoradiography (fig.3, inset). The ap- 
Fig.2. Incorporation of ‘*P into neuroblastoma proteins. 
Neuroblastoma cells were incubated with [‘*P]orthophosphate 
and the microtubule proteins prepared as described in section 2. 
The microtubule protein was electrophoresed on a 5.5% 
polyacrylamide gel slab [18]. The gel was stained with 
Coomassie blue and dried on filter paper. An autoradiograph 
of the dried gel is shown. Prior to autoradiography, spots of 
radioactive ink (*) were applied to the filter paper. One of the 
spots was next to the &-band. The positions of the cr-, fit- and 
&-bands are shown. 
proximate relative amounts of each pool that were 
spotted on nitrocellulose and shown in fig.3 were 
as follows (based on protein determination of the 
fractions eluted from the G-10 column and ex- 
pressed relative to pool I): pool I, 1 .O; pool II, 2.6; 
pool III, 3.0; pool IV, 0.7. Only pool I was found 
to contain any label. An autoradiogram, 
developed under identical conditions, of a 
nitrocellulose sheet spotted with double the 
amounts of pools II-IV showed no radioactivity in 
these peaks. The only peptide to elute at the posi- 
tion of pool I at the time when @-tubulin from pig 
brain was sequenced was the particularly large C- 
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Fig.3. Profile of the tryptic digest of,&-tubulin. The mixture of 
32P-labeled neuroblastoma and carrier bovine tubulin was 
digested with trypsin and the resulting peptides subjected to 
chromatography on Sephadex G-50. The figure shows the &so 
of the fractions. The fractions were grouped, as indicated on 
the figure, into pools I, II, III and IV. Samples from each pool 
in relative amounts of (I) 1.0, (II) 2.6, (III) 3.0 and (IV) 0.7 were 
spotted on a nitrocellulose sheet which was then subjected to 
autoradiography (inset). 
terminal tryptic peptide [25]. Our evidence 
therefore suggests that the label may be located in 
the C-terminal tryptic peptide. 
Gard and Kirschner [8] showed that when 
neuroblastoma cells are incubated with [32P]or- 
thophosphate, the phosphate label is attached to a 
serine residue in a &tubulin isotype. Our evidence 
suggests that the label is in the C-terminal tryptic 
peptide of the ,&-tubulin isotype. By sequencing 
&specific peptides it was possible to identify this 
isotype as corresponding to the type III fl-tubulin 
in the classification scheme of Sullivan and 
Cleveland [9,14]. 
Table 1 shows the published sequences of the 
vertebrate ,&tubulins C-terminal to arginine 380. It 
is noteworthy that two serines, those at positions 
413 and 420, are common to all of the fl-isotypes 
found in the brain. Similarly, the sequences in the 
vicinity of these serines are highly conserved. It is 
therefore highly unlikely that a protein kinase that 
phosphorylates erines would phosphorylate these 
serines in the type III ,&tubulin isotype and not in 
the others. It is much more likely that a protein 
kinase would phosphorylate only those serines that 
are unique to type III. These serines are the ones 
at positions 444 in chickens and humans and at 
Table I 
C-terminal sequences of mammalian and avian /Stubulins 
380 390 400 410 420 430 440 
Type 1” RISEQFTAflFRRKAFLHWYTGEGMDEMEFTEAESNMNDLV~EYQQYQDATAEEEED*FGEEAEEEAX 
Type 11 (PI)” D QGE* E G DEAX 
Type 111 UW GEMYEDDE S_EQGAKX 
Type 111 (P2Y GEMYEDDE S_ES_QGPKX 
Type IV? *GE* E VAX 
Type IV’ GE* E VAX 
Type VK s F E NDG EA EDDE INEX 
Type VP V 5 S_ GT DV **y AS_PEKETX 
4’ GE* E EX 
M/31’ V H S_ RV S_ IS_ G DIH F VR GL DS_*EEDA AEVEAEDKDHX 
‘Constitutive; sequenced in chicks, mice and humans [9,26] 
‘Major neuronal; sequenced in chicks and pigs [9] 
‘Minor neuronal; sequenced in chicks [9] 
‘Minor neuronal; sequenced in humans [9] 
‘Brain-specific; sequenced in humans and mice [9] 
‘Constituve; sequenced in humans and mice [9] 
8Ubiquitous, except brain; sequenced in chicks [9] 
‘Thrombocytes and erythrocytes; sequenced in chicks [27] 
i Testes; sequenced in chicks [9]. Recently classified as a form of type IV [26] 
j Bone marrow; sequenced in mice [lo] 
The table gives the C-terminal sequences of the known isotypes of ,&tubulin. Sequences tart at position 380; except for the sequence 
of type I, only those residues are indicated which occupy positions where the sequence differs from that of type I. The serines (S) are 
underlined 
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position 446 in humans. If the phosphorylation of 
&tubulin has a general physiological significance, 
then the likeliest of these two serine residues to be 
phosphorylated is serine 444 since that is common 
to the known,&(type III)-tubulins (table 1). It is in- 
teresting that the sequence at positions 434-440 
present in types II and IV but not in type III has 
been shown to be the site of interaction with the 
microtubule-associated proteins tau and MAP 2 
[ 181. The C-terminal sequence of the type III 
isotype differs from other ,&isotypes at positions 
436, 438, 439 and 440 [9]. It is possible that the 
type III isotype does not interact as well with tau 
and MAP 2 as do the other isotypes. It is con- 
ceivable, therefore, that the type III Btubulin has 
its assembly and/or function regulated by 
phosphorylation while the other isotypes are 
regulated by microtubule-associated proteins. 
Acknowledgements: We gratefully acknowledge the skilled 
technical assistance of Mrs Enulescu and the advice and 
assistance of Mr J. Kretschmer, and the gift of tubulin from Mr 
J. Buchholz. This research was supported by a visiting scien- 
tist’s stipend from the German Cancer Research Center and by 
grant GM23476 from the National Institutes of Health to 
R.F.L. 
REFERENCES 
111 
121 
t31 
[41 
[51 
Dustin, P. (1978) Microtubules, Springer, Berlin. 
Yamamoto, H., Fukunaga, K., Tanaka, E. and 
Miyamoto, E. (1983) J. Neurochem. 41, 1119-1125. 
Schulman, H. (1984) Mol. Cell. Biol. 4, 1175-1178. 
Theurkauf, W.E. and Vallee, R.B. (1983) J. Biol. Chem. 
258, 7883-7886. 
Luduena, R.F., Shooter, E.M. and Wilson, L. (1977) J. 
Biol. Chem. 252, 7006-7014. 
161 
171 
PI 
PI 
1101 
1111 
WI 
1131 
1141 
1151 
1161 
1171 
t181 
WI 
WI 
WI 
P21 
Eipper, B.A. (1972) Proc. Natl. Acad. Sci. USA 69, 
2283-2287. 
Eipper, B.A. (1974) J. Biol. Chem. 249, 1407-1416. 
Gard, D.L. and Kirschner, M.W. (1985) J. Cell Biol. 100, 
764-774. 
Sullivan, K.F. and Cleveland, D.W. (1986) Proc. Natl. 
Acad. Sci. USA 83, 4327-4331. 
Wang, D., Villasante, A., Lewis, S.A. and Cowan, N.J. 
(1986) J. Cell Biol. 103, 1903-1910. 
Sullivan, K.F., Machlin, P.S., Ratrie, H. and Cleveland, 
D.W. (1986) J. Biol. Chem. 261, 13317-13322. 
Sullivan, K.F. and Cleveland, D.W. (1984) J. Cell Biol. 
99, 1754-1760. 
Serrano, L., Diaz-Nido, J., Wandosell, F. and Avila, J. 
(1987) J. Cell Biol. 105, 1731-1739. 
Little, M. and Luduena, R.F. (1985) EMBO J. 4, 51-56. 
Little, M. (1979) FEBS Lett. 108, 283-286. 
Luduena, R.F., Roach, M.C., Trcka, P.P., Little, M., 
Palanivelu, P., Binkley, P. and Prasad, V. (1982) 
Biochemistry 21, 4787-4794. 
Little, M., Quinlan, R.A., Rohricht, C. and Diez, J. 
(1987) Biochim. Biophys. Acta 916, 83-88. 
Littauer, U.Z., Giveon, D., Thierauf, M., Ginzburg, I. 
and Ponstingl, H. (1986) Proc. Natl. Acad. Sci. USA 83, 
7162-7166. 
Jany, K.D., Keil, W., Meyer, H. and Kiltz, H.H. (1976) 
Biochim. Biophys. Acta 453, 62-66. 
Crestfield, A.M., Moore, S. and Stein, W.H. (1963) J. 
Biol. Chem. 238, 622-627. 
Laemmli, U.K. (1970) Nature 277, 680-685. 
Higgins, R.C. and Dahmus, M.E. (1979) Anal. Biochem. 
93, 257-260. 
[23] Lowry, D.H., Rosebrough, N.H., Farr, A.L. and 
Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. 
[24] Schacterle and Pollack (1973) Anal. Biochem. 51, 
654-655. 
[25] Krauhs, E., Little, M., Kempf, T., Hofer-Warbinek, R., 
Ade, W. and Ponstingl, H. (1981) Proc. Natl. Acad. Sci. 
USA 78, 4156-4160. 
[26] Joshi, H.C., Yen, T.J. and Cleveland, D.W. (1987) J. 
Cell Biol. 105, 2179-2190. 
[27] Murphy, D.B., Wallis, K.T., Machlin, P.S., Ratrie, H. iii 
and Cleveland, D.W. (1987) J. Biol. Chem. 262, 
14305-14312. 
146 
